TOP STORIES

• BUSINESS Chugai to Defer Domestic Supply of Elevidys amid Safety Review
  July 25, 2025

• REGULATORY Santen’s Glaucoma Drug, Taisho’s Insomnia Med Up for Panel Review on July 31
  July 25, 2025

• REGULATORY MHLW Plans to Ease Clinical Trial Ad Rules, Eyes Notification by March-End
  July 24, 2025

• BUSINESS Towa Launches Task Force to Tackle Nitrosamine Impurities, Share Solutions with Peers
  July 24, 2025

• REGULATORY New MHLW Drug Review Chief Aims to Dispel “Barrier” Perception, Pledges Active Engagement with Industry
  July 23, 2025

• REGULATORY Healthcare Stakeholders Weigh Fallout after Ruling Bloc’s Election Setback
  July 23, 2025

• REGULATORY Japan’s Ruling Bloc Routed in Upper House Poll; Takemi to Retire, Furukawa, Kamayachi, and Honda Secure Seats
  July 22, 2025

• BUSINESS JRI Urges Reforms in Pricing and Reimbursement to Support Regenerative Medicine Ecosystem
  July 18, 2025

• REGULATORY Japan Begins FY2026 CEA Reform Talks, Re-Designation after Market Expansion Up for Debate
  July 17, 2025

• REGULATORY Astellas Employee Sentenced to 3.5 Years in China for Spying
  July 17, 2025

• ORGANIZATION Industry Calls for More Tailored Govt Support on Drug Loss Product Development
  July 16, 2025

• BUSINESS Global Pharma Market Surges 9% to US$1.6 Trillion in 2024, Ozempic Overtakes Humira: IQVIA
  July 16, 2025

• BUSINESS Asahi Kasei Sharpens Acquisition Focus in Pharma Biz as Envarsus LOE Looms
  July 15, 2025

• REGULATORY Japan’s Major Parties Outline Various Drug Policy Visions Ahead of Upper House Poll
  July 14, 2025

• BUSINESS Espha President Signals Move Toward Novel Drug Development amid Group Shift
  July 11, 2025

• REGULATORY Leqembi Likely to Face 15% Price Cut Under Special CEA Rule
  July 10, 2025

• REGULATORY Pharma Groups Renew Push for Price Stability During Patent Term as FY2026 Reform Talks Begin
  July 10, 2025

• BUSINESS ASKA Targets 30% Overseas Sales Ratio through Southeast Asia Expansion: New President
  July 9, 2025

• REGULATORY AMED to Promote Earlier Out-Licensing to Industry to Bridge the “Devil’s River”: New Chief
  July 8, 2025

• REGULATORY Japan to Overhaul Diabetes Trial Guidelines to Align with Global Standards and Prevent Drug Lag/Loss
  July 7, 2025

ページ

• « 先頭
• ‹ Prev
• …
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• …
• Next ›
• 最終 »